News & Views

Read the latest from Baszucki Group and its partners.

New Survey Shows Poor Nutrition, Not Alcohol, Is the Real Crisis on College Campuses

On campuses across the country, college students aren’t pointing fingers at alcohol or drugs as the most significant health threat in their lives. According to a new national poll, the real crisis may be happening three times a day via what’s on their plates.

Read More

Food, Function, and the Future of Mental Health: A Mother’s Journey

As mental health challenges grow more complex and costly, new solutions are essential. What if one of the most powerful answers isn’t a new drug, but food? What if we’ve been missing an overlooked root cause of and a treatment approach to psychiatric suffering that science is now beginning to confirm?

Read More

Baszucki Group Announces Six Recipients of the Metabolic Psychiatry Scholar Award for Emerging Scientific Leaders Advancing Mental Health Innovation

Baszucki Group is proud to announce the six recipients of the first-ever Metabolic Psychiatry Scholar Award, a new initiative that supports exceptional early-career scientists and clinicians working to advance understanding of the connection between metabolic health and mental health. The award represents a significant step forward in growing the rapidly advancing field of metabolic psychiatry.

Read More

Erin Bellamy, PhD: Scaling Ketogenic Metabolic Therapy for Mental Health

Nearly a decade ago Dr. Erin Bellamy began questioning the limits of the current standard of care for inpatient psychiatric treatment. “I was working in an inpatient psychiatric unit and could see that my patients weren’t receiving lasting relief,” she says. Around the same time, new research on low-carbohydrate diets for Type 2 diabetes was making headlines, with some studies pointing to unexpected improvements in mood. These findings led Bellamy to dive into the literature on metabolic connections to psychiatry, where she found a small 1965 study that tested ketogenic diets as treatment for schizophrenia. To her surprise, the trial had never been pursued further. “I thought there had to be something there that warranted a closer look,” said Bellamy. “All I wanted to do was help people improve their mood and symptoms, and live a happy life.” 

Read More